In summary, our study presents an in-depth analysis of the humoral immune response to SARS-CoV-2 mRNA vaccination in patients with IBD who were treated with anti-TNF or anti-IL-12/23 compared with people in the healthy control group. Here, TNF is linked to inflammatory bowel disease.